Early resolution of herpes simplex virus type 2 infection of the murine genital tract involves stimulation of genital parenchymal cells by gamma interferon

Journal of Virology

Volumn 81, Issue 1, 2007, Pages 423-426

  Bird, Melanie D ^a,c   Chu, Chin Fun ^a   Johnson, Alison J ^a   Milligan, Gregg N ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FEMALE GENITAL TRACT INFECTION; GAMMA IRRADIATION; HEMATOPOIETIC CELL; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; RADIATION CHIMERA;

ANIMALS; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; INTERFERON TYPE II; MICE; MICE, INBRED C57BL; RECEPTORS, INTERFERON; T-LYMPHOCYTES; VAGINA;

HUMAN HERPESVIRUS 2; MURINAE;

EID: 33845772819     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01455-06     Document Type: Article

References (24)

1. Aguet, M., Z. Dembic, and G. Merlin. 1988. Molecular cloning and expression of the human interferon-gamma receptor. Cell 55:273-280.
2. Ashkar, A. A., and K. L. Rosenthal. 2003. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J. Virol. 77:10168-10171.
3. Bach, E. A., M. Aguet, and R. D. Schrieber. 1997. The IFN-gamma receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15:563-591.
4. Biron, C. A. 2001. Interferons alpha and beta as immune regulators-a new look. Immunity 14:661-664.
5. Cantin, E., B. Tanamachi, H. Openshaw, J. Mann, and K. Clarke. 1999. Gamma interferon (IFN-γ) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-γ ligand null-mutant mice. J. Virol. 73:5196-5200.
6. Cunningham, A. L., R. R. Turner, A. C. Miller, M. F. Para, and T. C. Merigan. 1985. Evolution of recurrent herpes simplex lesions. An immunohistologic study. J. Clin. Investig. 75:226-233.
7. + T cells requires gamma interferon and either perform- or Fas-mediated cytolytic mechanisms. J. Virol. 79:14546-14554.
8. Gill, N., K. L. Rosenthal, and A. A. Ashkar. 2005. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection. J. Virol. 79:4470-4478.
9. + T-cell-mediated immunopathology in chimeric mice deficient in gamma interferon receptor expression on both parenchymal and hematopoietic cells. J. Virol. 79:10073-10076.
10. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-gamma receptor. Science 259:1742-1745.
11. Ito, M., and J. A. O-Malley. 1987. Antiviral effects of recombinant human tumor necrosis factor. Lymphokine Res. 6:309-318.
12. Koelle, D. M., H. Abbo, A. Peck, K. Ziegweid, and L. Corey. 1994. Direct recovery of HSV-specific T lymphocyte clones from human recurrent HSV-2 lesions. J. Infect. Dis. 169:956-961.
13. Koelle, D. M., C. M. Posavad, G. R. Barnum, M. L. Johnson, J. M. Frank, and L. Corey. 1998. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J. Clin. Investig. 101:1500-1508.
14. Linehan, M. M., S. Richman, C. Krummenacher, R. J. Eisenberg, G. H. Cohen, and A. Iwasaki. 2004. In vivo role of nectin-1 in entry of herpes simplex virus type 1 (HSV-1) and HSV-2 through the vaginal mucosa. J. Virol. 78:2530-2536.
15. McDermott, M. R., J. R. Smiley, P. Leslie, J. Brais, H. E. Rudzroga, and J. Bienenstock. 1984. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J. Virol. 51:747-753.
16. Milligan, G. N. 1999. Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2. J. Virol. 73:6380-6386.
17. Milligan, G. N., and D. I. Bernstein. 1997. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 229:259-268.
18. Milligan, G. N., D. I. Bernstein, and N. Bourne. 1998. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J. Immunol. 160:6093-60100.
19. Mombaerts, P., J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa, and V. E. Papaioannou. 1992. RAG-1 deficient mice have no mature B and T lymphocytes. Cell 68:869-877.
20. Parr, M. B., and E. L. Parr. 1999. The role of gamma interferon in resistance to vaginal infection by herpes simplex type 2 in mice. Virology 258:282-294.
21. Rossol-Voth, R., S. Rossol, K. H. Schutt, W. de Cian, and D. Falke. 1991. In vivo protective effect of tumor necrosis factor alpha against experimental infection with herpes simplex virus type 1. J. Gen. Virol. 72:143-147.
22. Smith, P. M., R. M. Wolcott, R. Chervenak, and S. R. Jennings. 1994. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma). Virology 202:76-88.
23. Reference deleted.
24. Yu, Z., E. Manickan, and B. T. Rouse. 1996. Role of interferon-7 in immunity to herpes simplex virus. J. Leukoc. Biol. 60:528-532.